Â鶹AV

Registration is now closed. You can still show up but priority will be given to those who have registered.

On Thursday March 23rd, will hold a half-day conference in honour of World TB Day. Following the keynote address by Stephen Lewis, Part I will highlight problems around access to drugs and diagnostics for TB. Part II will feature a panel focused on potential solutions along the research and development continuum – from bench to bedside. The interdisciplinary panel will discuss the potential role of alternative research and licensing frameworks as well as stakeholders across the public and private sectors.

This event will be co-hosted by Â鶹AV Global Health Programs, the Â鶹AV International TB Centre, , the Â鶹AV Institute for the Study of International Development and .

Speaker bios available here

Ìý

Ìý

Keynote address by Stephen Lewis, Co-director, AIDS-Free World

Other Speakers

• Madhukar Pai, Director, Â鶹AV Global Health Programs

• Jennifer Furin, MD, PhD, Harvard University

• Grania Brigden, 3P Project Lead, International Union Against Tuberculosis and Lung Disease

• Rachel Kiddell-Monroe, Special Advisor, Universities Allied for Essential Medicines, Professor of Practice, Â鶹AV Institute for the Study of International Development

• Jason Nickerson, Humanitarian Affairs Advisor, Médecins Sans Frontières Canada / Doctors Without Borders

• Chris Walpole, Structure-Guided Drug-Discovery Coalition Project Lead, Structural Genomics Consortium

• Rachel Cohen, Regional Executive Director, Drugs for Neglected Diseases Initiative North America

ÌýÌý Ìý ÌýÌý

Register here